2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide

C139H146Cl2N44O16 — CID 167549836

IUPAC2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide
SMILESCC(C)CC(=O)NCCOc1ccc(-c2nc(Nc3ccc4[nH]ncc4c3)n[nH]2)cc1.CC(C)NC(=O)COc1ccc(-c2nc(Nc3ccc4[nH]ncc4c3Cl)n(C)n2)cc1N1CCOCC1.CC(C)NC(=O)COc1ccc(-c2nnc(Nc3ccc4[nH]ncc4c3)n2-c2ccccn2)cc1.COc1cc(-c2nc(Nc3ccc4[nH]ncc4c3Cl)n(C)n2)ccc1OCC(=O)NC1CCOC1.COc1cc(-c2nnc(Nc3ccc4[nH]ncc4c3)n2-c2ccccn2)ccc1OCC(=O)NC(C)C.COc1ccc(-c2nc(Nc3ccc4[nH]ncc4c3)nn2C)cc1OC
InChIInChI=1S/C26H26N8O3.C25H29ClN8O3.C25H24N8O2.C23H24ClN7O4.C22H25N7O2.C18H18N6O2/c1-16(2)29-24(35)15-37-21-10-7-17(13-22(21)36-3)25-32-33-26(34(25)23-6-4-5-11-27-23)30-19-8-9-20-18(12-19)14-28-31-20;1-15(2)28-22(35)14-37-21-7-4-16(12-20(21)34-8-10-36-11-9-34)24-30-25(33(3)32-24)29-19-6-5-18-17(23(19)26)13-27-31-18;1-16(2)28-23(34)15-35-20-9-6-17(7-10-20)24-31-32-25(33(24)22-5-3-4-12-26-22)29-19-8-11-21-18(13-19)14-27-30-21;1-31-23(27-17-5-4-16-15(21(17)24)10-25-29-16)28-22(30-31)13-3-6-18(19(9-13)33-2)35-12-20(32)26-14-7-8-34-11-14;1-14(2)11-20(30)23-9-10-31-18-6-3-15(4-7-18)21-26-22(29-28-21)25-17-5-8-19-16(12-17)13-24-27-19;1-24-17(11-4-7-15(25-2)16(9-11)26-3)21-18(23-24)20-13-5-6-14-12(8-13)10-19-22-14/h4-14,16H,15H2,1-3H3,(H,28,31)(H,29,35)(H,30,33);4-7,12-13,15H,8-11,14H2,1-3H3,(H,27,31)(H,28,35)(H,29,30,32);3-14,16H,15H2,1-2H3,(H,27,30)(H,28,34)(H,29,32);3-6,9-10,14H,7-8,11-12H2,1-2H3,(H,25,29)(H,26,32)(H,27,28,30);3-8,12-14H,9-11H2,1-2H3,(H,23,30)(H,24,27)(H2,25,26,28,29);4-10H,1-3H3,(H,19,22)(H,20,23)
InChIKeyCGMHILNGZJFYEJ-UHFFFAOYSA-N
MW2759.89 g/mol
LogP21.01
Rot. Bonds47

About 2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide

2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide (PubChem CID 167549836) has the molecular formula C139H146Cl2N44O16 and a molecular weight of 2759.89 g/mol. Its IUPAC name is 2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide.

Molecular Properties

Compound Name2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide
PubChem CID167549836
Molecular FormulaC139H146Cl2N44O16
Molecular Weight2759.89 g/mol
Exact Mass2757.13
IUPAC Name2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide
SMILESCC(C)CC(=O)NCCOc1ccc(-c2nc(Nc3ccc4[nH]ncc4c3)n[nH]2)cc1.CC(C)NC(=O)COc1ccc(-c2nc(Nc3ccc4[nH]ncc4c3Cl)n(C)n2)cc1N1CCOCC1.CC(C)NC(=O)COc1ccc(-c2nnc(Nc3ccc4[nH]ncc4c3)n2-c2ccccn2)cc1.COc1cc(-c2nc(Nc3ccc4[nH]ncc4c3Cl)n(C)n2)ccc1OCC(=O)NC1CCOC1.COc1cc(-c2nnc(Nc3ccc4[nH]ncc4c3)n2-c2ccccn2)ccc1OCC(=O)NC(C)C.COc1ccc(-c2nc(Nc3ccc4[nH]ncc4c3)nn2C)cc1OC
InChIInChI=1S/C26H26N8O3.C25H29ClN8O3.C25H24N8O2.C23H24ClN7O4.C22H25N7O2.C18H18N6O2/c1-16(2)29-24(35)15-37-21-10-7-17(13-22(21)36-3)25-32-33-26(34(25)23-6-4-5-11-27-23)30-19-8-9-20-18(12-19)14-28-31-20;1-15(2)28-22(35)14-37-21-7-4-16(12-20(21)34-8-10-36-11-9-34)24-30-25(33(3)32-24)29-19-6-5-18-17(23(19)26)13-27-31-18;1-16(2)28-23(34)15-35-20-9-6-17(7-10-20)24-31-32-25(33(24)22-5-3-4-12-26-22)29-19-8-11-21-18(13-19)14-27-30-21;1-31-23(27-17-5-4-16-15(21(17)24)10-25-29-16)28-22(30-31)13-3-6-18(19(9-13)33-2)35-12-20(32)26-14-7-8-34-11-14;1-14(2)11-20(30)23-9-10-31-18-6-3-15(4-7-18)21-26-22(29-28-21)25-17-5-8-19-16(12-17)13-24-27-19;1-24-17(11-4-7-15(25-2)16(9-11)26-3)21-18(23-24)20-13-5-6-14-12(8-13)10-19-22-14/h4-14,16H,15H2,1-3H3,(H,28,31)(H,29,35)(H,30,33);4-7,12-13,15H,8-11,14H2,1-3H3,(H,27,31)(H,28,35)(H,29,30,32);3-14,16H,15H2,1-2H3,(H,27,30)(H,28,34)(H,29,32);3-6,9-10,14H,7-8,11-12H2,1-2H3,(H,25,29)(H,26,32)(H,27,28,30);3-8,12-14H,9-11H2,1-2H3,(H,23,30)(H,24,27)(H2,25,26,28,29);4-10H,1-3H3,(H,19,22)(H,20,23)
InChIKeyCGMHILNGZJFYEJ-UHFFFAOYSA-N
XLogP21.01
TPSA715.43 Ų
H-Bond Donors18
H-Bond Acceptors48
Rotatable Bonds47
Heavy Atoms201
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002759.89
LogP ≤ 521.01
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1048

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide?
The IUPAC name of 2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide (CID 167549836) is 2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide.
What is the SMILES notation for 2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide?
The canonical SMILES for 2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide is CC(C)CC(=O)NCCOc1ccc(-c2nc(Nc3ccc4[nH]ncc4c3)n[nH]2)cc1.CC(C)NC(=O)COc1ccc(-c2nc(Nc3ccc4[nH]ncc4c3Cl)n(C)n2)cc1N1CCOCC1.CC(C)NC(=O)COc1ccc(-c2nnc(Nc3ccc4[nH]ncc4c3)n2-c2ccccn2)cc1.COc1cc(-c2nc(Nc3ccc4[nH]ncc4c3Cl)n(C)n2)ccc1OCC(=O)NC1CCOC1.COc1cc(-c2nnc(Nc3ccc4[nH]ncc4c3)n2-c2ccccn2)ccc1OCC(=O)NC(C)C.COc1ccc(-c2nc(Nc3ccc4[nH]ncc4c3)nn2C)cc1OC.
What is the InChIKey of 2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide?
The InChIKey is CGMHILNGZJFYEJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H26N8O3.C25H29ClN8O3.C25H24N8O2.C23H24ClN7O4.C22H25N7O2.C18H18N6O2/c1-16(2)29-24(35)15-37-21-10-7-17(13-22(21)36-3)25-32-33-26(34(25)23-6-4-5-11-27-23)30-19-8-9-20-18(12-19)14-28-31-20;1-15(2)28-22(35)14-37-21-7-4-16(12-20(21)34-8-10-36-11-9-34)24-30-25(33(3)32-24)29-19-6-5-18-17(23(19)26)13-27-31-18;1-16(2)28-23(34)15-35-20-9-6-17(7-10-20)24-31-32-25(33(24)22-5-3-4-12-26-22)29-19-8-11-21-18(13-19)14-27-30-21;1-31-23(27-17-5-4-16-15(21(17)24)10-25-29-16)28-22(30-31)13-3-6-18(19(9-13)33-2)35-12-20(32)26-14-7-8-34-11-14;1-14(2)11-20(30)23-9-10-31-18-6-3-15(4-7-18)21-26-22(29-28-21)25-17-5-8-19-16(12-17)13-24-27-19;1-24-17(11-4-7-15(25-2)16(9-11)26-3)21-18(23-24)20-13-5-6-14-12(8-13)10-19-22-14/h4-14,16H,15H2,1-3H3,(H,28,31)(H,29,35)(H,30,33);4-7,12-13,15H,8-11,14H2,1-3H3,(H,27,31)(H,28,35)(H,29,30,32);3-14,16H,15H2,1-2H3,(H,27,30)(H,28,34)(H,29,32);3-6,9-10,14H,7-8,11-12H2,1-2H3,(H,25,29)(H,26,32)(H,27,28,30);3-8,12-14H,9-11H2,1-2H3,(H,23,30)(H,24,27)(H2,25,26,28,29);4-10H,1-3H3,(H,19,22)(H,20,23).
What are the key properties of 2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide?
2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide has a molecular weight of 2759.89 g/mol, XLogP of 21.01, 47 rotatable bonds, 18 hydrogen bond donors, and 48 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-(oxolan-3-yl)acetamide;2-[4-[5-[(4-chloro-1H-indazol-5-yl)amino]-1-methyl-1,2,4-triazol-3-yl]-2-morpholin-4-ylphenoxy]-N-propan-2-ylacetamide;N-[5-(3,4-dimethoxyphenyl)-1-methyl-1,2,4-triazol-3-yl]-1H-indazol-5-amine;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]-2-methoxyphenoxy]-N-propan-2-ylacetamide;2-[4-[5-(1H-indazol-5-ylamino)-4-pyridin-2-yl-1,2,4-triazol-3-yl]phenoxy]-N-propan-2-ylacetamide;N-[2-[4-[3-(1H-indazol-5-ylamino)-1H-1,2,4-triazol-5-yl]phenoxy]ethyl]-3-methylbutanamide is sourced from PubChem (CID 167549836), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).